Pan-Asia Catalysts/Events, Quiddity Advisors

Travis Lundy

HK Type 4 license through Ballingal Investment Advisors Ltd. ("BIA" or "BIAL")

BACKGROUND
I have 20+yrs experience in Asia doing alternative strategies (i.e. non-delta1 non long-only) in fixed income, equity derivatives, and activist/catalyst/event-driven and long-short equity strategies with most of that time spent managing money. 

4 years in fixed income macro, 8 years running internal hedge fund and 4yrs investment banking at Citi in Japan, 3 years running an Asia multi-strat portfolio at a hedge fund, 4+yrs as an independent special situations analyst.

Pan-Asia Catalysts/Events

[Quiddity Index] The TOPIX Change in Oct 2026 - Part I (Methodology Madness)

[Quiddity Index] The TOPIX Change in Oct 2026 - Part II (Regional Bank LFR Baskets)

Quiddity Leaderboard CSI Medical Dec26: Expected ADDs Are Underperforming Expected DELs

[Japan Activism/Value] - Mitsui Matsushima (1518) Beats; Single Digit PER, Double Digit ROE & Growth

[Japan Activism] Mitsui Matsushima (1518) Ups Buyback Tender to 35.8%, Murakami-San Group To Sell

[Japan Activism] Mitsui Matsushima (1518 JP) Buyback Tender - Surprising Results and Implications

Quiddity Advisors

Event-Driven

<ul>
<li>Today, <a href="https://www.smartkarma.com/entities/mitsui-matsushima-co-ltd" target="_blank" data-smartkarma-citation="entities:13569:1" rel="noopener">Mitsui Matsushima (1518 JP)</a> upped full-year guidance, lifting revenue by 4.4%, OP by 3%, and NP by 21% (at earnings, they guided revenue +3.9%yoy, NP +5.7%yoy after decent beats.</li>
<li>Today, they announced the purchase of an asset-rich q-tip maker with 10% OPMs and NPMs &gt;OPMs on ¥3.6bn revenue the last 3yrs. Deal closes August. We'll know more in September.</li>
<li>The earnings uplift is frankly not that impressive. There were stock sale gains, and the uplift in consolidated numbers from the buy. But the dividend hike is REALLY impressive.</li>
</ul>


Today, Mitsui Matsushima (1518 JP) upped full-year guidance, lifting revenue by 4.4%, OP by 3%, and NP by 21% (at earnings, they guided revenue +3.9%yoy, NP +5.7%yoy after decent beats.
Today, they announced the purchase of an asset-rich q-tip maker with 10% OPMs and NPMs &gt;OPMs on ¥3.6bn revenue the last 3yrs. Deal closes August. We'll know more in September.
The earnings uplift is frankly not that impressive. There were stock sale gains, and the uplift in consolidated numbers from the buy. But the dividend hike is REALLY impressive.


[Japan Activism/Value] - Mitsui Matsushima (1518) Raises; Low PER, High ROE/Growth (Still), Now Div!